# Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin

> **NCT00203658** · PHASE4 · COMPLETED · sponsor: **University of Calgary** · enrollment: 400 (—)

## Conditions studied

- Thrombosis
- Thromboembolism
- Venous Thrombosis

## Interventions

- **DRUG:** Tinzaparin sodium

## Key facts

- **NCT ID:** NCT00203658
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-04
- **Primary completion:** —
- **Final completion:** 2000-10
- **Target enrollment:** 400 (—)
- **Last updated:** 2007-02-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00203658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00203658, "Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00203658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
